title: Immune thrombocytopenia resulting from sensitivity to metabolites of naproxen and acetaminophen.
abstract: In patients suspected of having drug-induced immune thrombocytopenia, antibodies reactive with normal platelets in the presence of the suspect drug can sometimes be identified, but negative results are often obtained. One reason for this is that drug metabolites, formed in vivo, can be the sensitizing agents, but very little is known about the specific metabolites that can cause this complication. Five patients were studied who developed thrombocytopenia after taking the nonsteroidal anti-inflammatory drug naproxen (3 cases) or acetaminophen (2 cases) but in whom drug-dependent antibodies could not be detected by means of the unmodified drugs. In each case, antibodies that reacted with normal target platelets in the presence of a known drug metabolite (naproxen glucuronide or acetaminophen sulfate) were identified. Four of the antibodies were specific for the glycoprotein (GP) IIb/IIIa complex, but one acetaminophen sulfate-dependent antibody reacted preferentially with GPIb/IX/V. In patients with a clinical picture suggestive of drug-induced immune thrombocytopenia, tests for metabolite-dependent antibodies can be helpful in identifying the responsible agent. (Blood. 2001;97:3846-3850)
authors.affiliation: Blood Research Institute, The Blood Center of Southeastern Wisconsin, PO Box 2178, Milwaukee, WI 53201-2178, USA. dwbougie@bcsew.edu
authors.forename: D
authors.initials: D
authors.lastname: Bougie
authors.forename: R
authors.initials: R
authors.lastname: Aster
mesh_terms: D000082:Acetaminophen / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000276:immunology / Q000378:metabolism / Q000652:urine; D000328:Adult; D000368:Aged; D000906:Antibodies / Q000097:blood / Q000187:drug effects; D001792:Blood Platelets / Q000276:immunology; D005260:Female; D020719:Glucuronides / Q000276:immunology / Q000652:urine; D006801:Humans; D008297:Male; D008875:Middle Aged; D009288:Naproxen / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives / Q000276:immunology / Q000378:metabolism / Q000652:urine; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000276:immunology; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000139:chemically induced* / Q000276:immunology
chemical_list: D000906:Antibodies; D020719:Glucuronides; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; C430408:naproxen glucuronide; D000082:Acetaminophen; D009288:Naproxen; C037386:acetaminophen glucuronide; C045667:acetaminophen sulfate ester